Global Veterinary Healthcare Market: By Product Type (Drugs (Antibiotics, Antifungal, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Drugs for Chronic Diseases, and Others), Vaccines, and Feed Additives (Nutritional Feed Additives and Medicinal Feed Additives)), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Veterinary/Animal Healthcare Market Report Description:
Veterinary/Animal healthcare market report gives comprehensive outlook on veterinary/animal healthcare market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary/animal healthcare market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies veterinary/animal healthcare market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, veterinary/animal healthcare market report includes animal demographics; regulatory scenario, top meat producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary/animal healthcare market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary/animal healthcare market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary/animal healthcare products.
Global Veterinary/Animal Healthcare Market:
The veterinary/animal healthcare market estimated to be valued US$ 35.8 Bn in 2017 and poised to grow at CAGR of 4.7% over 2017-2023. Market for Veterinary/Animal Healthcare projected to reach US$ 47.1 Bn by 2023 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe.
Rising pet adoption and meat consumption expected drive animal healthcare market
The rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period. Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large scale production of animals in the form of factory farming expected to boost the animal healthcare market. Animals have long been considered as source of food for the human being and it’s been shifting towards companionship to the humans. As there is a growing interaction between humans and animals prompting the key stakeholders to give attention to animal healthcare
Increasing incidences of zoonotic diseases prompting the adoption of animal healthcare products for various ailments in animals
The rising incidences of zoonotic disease in several developed and developing countries expected to create demand for animal healthcare products like drugs and vaccines over the forecast period. According to U.S. Centre for disease control and prevention (CDC) every year tens of thousands of people get sick due to disease spread from animals to humans and it is believed that more than six out of every 10 known infectious diseases in people are spread from animals, and three out of every four new or emerging infectious diseases in people are spread from animals, which can prevented by appropriate healthcare to animals.
North America accounts for larger market revenue share in global veterinary/animal healthcare market
North America accounted for larger revenue share in global animal healthcare market with moderate CAGR. There has been increase in awareness among cattlemen in U.S. regarding animal rearing, animal health and proper vaccination and judicious use of antibiotics in animals, which are driving the market revenue growth in the region. Asia pacific market projected to grow at significant rate owing large pool of animal population coupled with increased incidences of several zoonotic diseases.
COMPETITION ASSESSMENT
Key players profiles in the global veterinary/animal healthcare market include:
KEY FINDINGS OF THE REPORT:
By Product Type
Veterinary/Animal healthcare market report gives comprehensive outlook on veterinary/animal healthcare market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary/animal healthcare market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies veterinary/animal healthcare market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, veterinary/animal healthcare market report includes animal demographics; regulatory scenario, top meat producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary/animal healthcare market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary/animal healthcare market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary/animal healthcare products.
Global Veterinary/Animal Healthcare Market:
The veterinary/animal healthcare market estimated to be valued US$ 35.8 Bn in 2017 and poised to grow at CAGR of 4.7% over 2017-2023. Market for Veterinary/Animal Healthcare projected to reach US$ 47.1 Bn by 2023 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe.
Rising pet adoption and meat consumption expected drive animal healthcare market
The rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period. Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large scale production of animals in the form of factory farming expected to boost the animal healthcare market. Animals have long been considered as source of food for the human being and it’s been shifting towards companionship to the humans. As there is a growing interaction between humans and animals prompting the key stakeholders to give attention to animal healthcare
Increasing incidences of zoonotic diseases prompting the adoption of animal healthcare products for various ailments in animals
The rising incidences of zoonotic disease in several developed and developing countries expected to create demand for animal healthcare products like drugs and vaccines over the forecast period. According to U.S. Centre for disease control and prevention (CDC) every year tens of thousands of people get sick due to disease spread from animals to humans and it is believed that more than six out of every 10 known infectious diseases in people are spread from animals, and three out of every four new or emerging infectious diseases in people are spread from animals, which can prevented by appropriate healthcare to animals.
North America accounts for larger market revenue share in global veterinary/animal healthcare market
North America accounted for larger revenue share in global animal healthcare market with moderate CAGR. There has been increase in awareness among cattlemen in U.S. regarding animal rearing, animal health and proper vaccination and judicious use of antibiotics in animals, which are driving the market revenue growth in the region. Asia pacific market projected to grow at significant rate owing large pool of animal population coupled with increased incidences of several zoonotic diseases.
COMPETITION ASSESSMENT
Key players profiles in the global veterinary/animal healthcare market include:
- Bayer AG (Germany)
- Boehringer Ingelheim GmbH (Germany)
- Cargill, Inc. (U.S)
- Ceva Santé Animale (France)
- Eli Lilly and Company (U.S)
- Koninklijke DSM N.V. (Netherlands)
- Merck & Co., Inc. (U.S)
- Novartis AG (Switzerland)
- Nutreco N.V. (Netherlands)
- SeQuent Scientific Ltd. (India)
- Vétoquinol S.A. (France)
- Virbac S.A. (France)
- Zoetis Inc. (U.S)
KEY FINDINGS OF THE REPORT:
- Veterinary/Animal healthcare market expanding at 4.7% CAGR over 2017 to 2023 to reach market value of US$ 47.1 Bn by 2023 owing to increased adoption pet animals and rising meat consumption
- Based on product type feed additives accounted for larger market revenue share in 2016 and projected gain market revenue share over the forecast period
- Farm animals segment garnered larger revenue share in global 2016 owing to increased animal rearing in several developing and under developed countries
- Players focusing on mergers and acquisitions strategies to retain market position in global animal healthcare market
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Product Type
- Drugs
- Antibiotics
- Antifungal
- Ectoparasiticides
- Endoparacitides
- Endectoparaciticides
- Anti-inflammatory Drugs
- Drugs for Chronic Diseases
- Others
- Vaccines
- Feed Additives
- Nutritional Feed Additives
- Medicinal Feed Additives
- Farm Animals
- Livestock
- Poultry
- Swine
- Equine
- Companion Animals
- Feline
- Canine
- Avian
- Aquaculture
- Oral
- Parenteral
- Topical
- Others
- Veterinary Pharmacies
- Veterinary Hospitals
- Veterinary Clinics
- E-Commerce
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL VETERINARY HEALTHCARE MARKET DYNAMIC FACTORS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.1.1. Dash board of top players
5.1.2. Financial Analysis
5.1.3. Product & Services
5.1.4. Key Developments
5.1.5. Major Strategies
5.1.6. SWOT Analysis
5.2. Technological advancements in veterinary healthcare market
5.3. Recent investments in the industry
5.4. Regulatory landscape
5.4.1. U.S.
5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis
6. GLOBAL VETERINARY HEALTHCARE MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Product Type
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.3. Drugs
6.1.3.1. Antibiotics
6.1.3.2. Antifungal
6.1.3.3. Ectoparasiticides
6.1.3.4. Endoparacitides
6.1.3.5. Endectoparaciticides
6.1.3.6. Anti-inflammatory Drugs
6.1.3.7. Drugs for Chronic Diseases
6.1.3.8. Others
6.1.4. Vaccines
6.1.5. Feed Additives
6.1.5.1. Nutritional Feed Additives
6.1.5.2. Medicinal Feed Additives
7. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Farm Animals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.3. Livestock
7.1.4. Poultry
7.1.5. Swine
7.1.6. Equine
7.2. Companion Animal
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.3. Feline
7.2.4. Canine
7.2.5. Avian
7.3. Aqua Culture
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Oral
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Parenteral
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Topical
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Others
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Veterinary Hospitals
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. VETERINARY HEALTHCARE MARKET FORECAST, BY REGION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.1.1. Product type
10.1.1.1.1. Drugs
10.1.1.1.1.1. Antibiotics
10.1.1.1.1.2. Antifungal
10.1.1.1.1.3. Ectoparasiticides
10.1.1.1.1.4. Endoparacitides
10.1.1.1.1.5. Endectoparaciticides
10.1.1.1.1.6. Anti-inflammatory Drugs
10.1.1.1.1.7. Drugs for Chronic Diseases
10.1.1.1.1.8. Others
10.1.1.1.2. Vaccines
10.1.1.1.3. Feed Additives
10.1.1.1.3.1. Nutritional Feed Additives
10.1.1.1.3.2. Medicinal Feed Additives
10.1.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.2.1. Farm Animal
10.1.2.1.1. Livestock
10.1.2.1.2. Poultry
10.1.2.1.3. Swine
10.1.2.1.4. Equine
10.1.2.2. Companion Animal
10.1.2.2.1. Feline
10.1.2.2.2. Canine
10.1.2.2.3. Avian
10.1.2.2.4. Others
10.1.2.3. Aquaculture
10.1.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.3.1. Oral
10.1.3.2. Parenteral
10.1.3.3. Topical
10.1.3.4. Others
10.1.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.4.1. Veterinary Pharmacies
10.1.4.2. Veterinary Hospitals
10.1.4.3. Veterinary Clinics
10.1.4.4. E-Commerce
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.2. Europe Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.2.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.1.1. Product type
10.2.1.1.1. Drugs
10.2.1.1.1.1. Antibiotics
10.2.1.1.1.2. Antifungal
10.2.1.1.1.3. Ectoparasiticides
10.2.1.1.1.4. Endoparacitides
10.2.1.1.1.5. Endectoparaciticides
10.2.1.1.1.6. Anti-inflammatory Drugs
10.2.1.1.1.7. Drugs for Chronic Diseases
10.2.1.1.1.8. Others
10.2.1.1.2. Vaccines
10.2.1.1.3. Feed Additives
10.2.1.1.3.1. Nutritional Feed Additives
10.2.1.1.3.2. Medicinal Feed Additives
10.2.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.2.1. Farm Animal
10.2.2.1.1. Livestock
10.2.2.1.2. Poultry
10.2.2.1.3. Swine
10.2.2.1.4. Equine
10.2.2.2. Companion Animal
10.2.2.2.1. Feline
10.2.2.2.2. Canine
10.2.2.2.3. Avian
10.2.2.2.4. Others
10.2.2.3. Aquaculture
10.2.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.3.1. Oral
10.2.3.2. Parenteral
10.2.3.3. Topical
10.2.3.4. Others
10.2.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.4.1. Veterinary Pharmacies
10.2.4.2. Veterinary Hospitals
10.2.4.3. Veterinary Clinics
10.2.4.4. E-Commerce
10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.5.1. Germany
10.2.5.2. UK
10.2.5.3. France
10.2.5.4. Spain
10.2.5.5. Italy
10.2.5.6. Russia
10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.3.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.1.1. Product type
10.3.1.1.1. Drugs
10.3.1.1.1.1. Antibiotics
10.3.1.1.1.2. Antifungal
10.3.1.1.1.3. Ectoparasiticides
10.3.1.1.1.4. Endoparacitides
10.3.1.1.1.5. Endectoparaciticides
10.3.1.1.1.6. Anti-inflammatory Drugs
10.3.1.1.1.7. Drugs for Chronic Diseases
10.3.1.1.1.8. Others
10.3.1.1.2. Vaccines
10.3.1.1.3. Feed Additives
10.3.1.1.3.1. Nutritional Feed Additives
10.3.1.1.3.2. Medicinal Feed Additives
10.3.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.2.1. Farm Animal
10.3.2.1.1. Livestock
10.3.2.1.2. Poultry
10.3.2.1.3. Swine
10.3.2.1.4. Equine
10.3.2.2. Companion Animal
10.3.2.2.1. Feline
10.3.2.2.2. Canine
10.3.2.2.3. Avian
10.3.2.2.4. Others
10.3.2.3. Aquaculture
10.3.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.3.1. Oral
10.3.3.2. Parenteral
10.3.3.3. Topical
10.3.3.4. Others
10.3.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.4.1. Veterinary Pharmacies
10.3.4.2. Veterinary Hospitals
10.3.4.3. Veterinary Clinics
10.3.4.4. E-Commerce
10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.5.1. Japan
10.3.5.2. China
10.3.5.3. India
10.3.5.4. ASEAN
10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.4.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.1.1. Product type
10.4.1.1.1. Drugs
10.4.1.1.1.1. Antibiotics
10.4.1.1.1.2. Antifungal
10.4.1.1.1.3. Ectoparasiticides
10.4.1.1.1.4. Endoparacitides
10.4.1.1.1.5. Endectoparaciticides
10.4.1.1.1.6. Anti-inflammatory Drugs
10.4.1.1.1.7. Drugs for Chronic Diseases
10.4.1.1.1.8. Others
10.4.1.1.2. Vaccines
10.4.1.1.3. Feed Additives
10.4.1.1.3.1. Nutritional Feed Additives
10.4.1.1.3.2. Medicinal Feed Additives
10.4.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.2.1. Farm Animal
10.4.2.1.1. Livestock
10.4.2.1.2. Poultry
10.4.2.1.3. Swine
10.4.2.1.4. Equine
10.4.2.2. Companion Animal
10.4.2.2.1. Feline
n) and Y-o-Y Growth (%)
10.4.3.1. Oral
10.4.3.2. Parenteral
10.4.3.3. Topical
10.4.3.4. Others
10.4.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.4.1. Veterinary Pharmacies
10.4.4.2. Veterinary Hospitals
10.4.4.3. Veterinary Clinics
10.4.4.4. E-Commerce
10.4.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.5.1. Brazil
10.4.5.2. Mexico
10.4.5.3. Argentina
10.4.5.4. Venezuela
10.4.5.5. Rest of Latin America
10.5. Middle East & Africa (MEA) Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.5.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.1.1. Product type
10.5.1.1.1. Drugs
10.5.1.1.1.1. Antibiotics
10.5.1.1.1.2. Antifungal
10.5.1.1.1.3. Ectoparasiticides
10.5.1.1.1.4. Endoparacitides
10.5.1.1.1.5. Endectoparaciticides
10.5.1.1.1.6. Anti-inflammatory Drugs
10.5.1.1.1.7. Drugs for Chronic Diseases
10.5.1.1.1.8. Others
10.5.1.1.2. Vaccines
10.5.1.1.3. Feed Additives
10.5.1.1.3.1. Nutritional Feed Additives
10.5.1.1.3.2. Medicinal Feed Additives
10.5.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.2.1. Farm Animal
10.5.2.1.1. Livestock
10.5.2.1.2. Poultry
10.5.2.1.3. Swine
10.5.2.1.4. Equine
10.5.2.2. Companion Animal
10.5.2.2.1. Feline
10.5.2.2.2. Canine
10.5.2.2.3. Avian
10.5.2.2.4. Others
10.5.2.3. Aquaculture
10.5.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.3.1. Oral
10.5.3.2. Parenteral
10.5.3.3. Topical
10.5.3.4. Others
10.5.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.4.1. Veterinary Pharmacies
10.5.4.2. Veterinary Hospitals
10.5.4.3. Veterinary Clinics
10.5.4.4. E-Commerce
10.5.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.5.1. Gulf Cooperation Council (GCC) Countries
10.5.5.2. Israel
10.5.5.3. South Africa
10.5.5.4. Rest of MEA
11. COMPETITION LANDSCAPE
11.1. Strategic Dashboard of Top Market Players
11.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
11.2.1. Bayer AG (Germany)
11.2.2. Boehringer Ingelheim GmbH (Germany)
11.2.3. Cargill, Inc. (U.S)
11.2.4. Ceva Santé Animale (France)
11.2.5. Eli Lilly and Company (U.S)
11.2.6. Koninklijke DSM N.V. (Netherlands)
11.2.7. Merck & Co., Inc. (U.S)
11.2.8. Novartis AG (Switzerland)
11.2.9. Nutreco N.V. (Netherlands)
11.2.10. SeQuent Scientific Ltd. (India)
11.2.11. Vétoquinol S.A. (France)
11.2.12. Virbac S.A. (France)
11.2.13. Zoetis Inc. (
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL VETERINARY HEALTHCARE MARKET DYNAMIC FACTORS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.1.1. Dash board of top players
5.1.2. Financial Analysis
5.1.3. Product & Services
5.1.4. Key Developments
5.1.5. Major Strategies
5.1.6. SWOT Analysis
5.2. Technological advancements in veterinary healthcare market
5.3. Recent investments in the industry
5.4. Regulatory landscape
5.4.1. U.S.
5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis
6. GLOBAL VETERINARY HEALTHCARE MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Product Type
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.3. Drugs
6.1.3.1. Antibiotics
6.1.3.2. Antifungal
6.1.3.3. Ectoparasiticides
6.1.3.4. Endoparacitides
6.1.3.5. Endectoparaciticides
6.1.3.6. Anti-inflammatory Drugs
6.1.3.7. Drugs for Chronic Diseases
6.1.3.8. Others
6.1.4. Vaccines
6.1.5. Feed Additives
6.1.5.1. Nutritional Feed Additives
6.1.5.2. Medicinal Feed Additives
7. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY ANIMAL, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Farm Animals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.3. Livestock
7.1.4. Poultry
7.1.5. Swine
7.1.6. Equine
7.2. Companion Animal
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.3. Feline
7.2.4. Canine
7.2.5. Avian
7.3. Aqua Culture
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Oral
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Parenteral
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Topical
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Others
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. GLOBAL VETERINARY HEALTHCARE MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Veterinary Hospitals
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. VETERINARY HEALTHCARE MARKET FORECAST, BY REGION ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.1.1. Product type
10.1.1.1.1. Drugs
10.1.1.1.1.1. Antibiotics
10.1.1.1.1.2. Antifungal
10.1.1.1.1.3. Ectoparasiticides
10.1.1.1.1.4. Endoparacitides
10.1.1.1.1.5. Endectoparaciticides
10.1.1.1.1.6. Anti-inflammatory Drugs
10.1.1.1.1.7. Drugs for Chronic Diseases
10.1.1.1.1.8. Others
10.1.1.1.2. Vaccines
10.1.1.1.3. Feed Additives
10.1.1.1.3.1. Nutritional Feed Additives
10.1.1.1.3.2. Medicinal Feed Additives
10.1.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.2.1. Farm Animal
10.1.2.1.1. Livestock
10.1.2.1.2. Poultry
10.1.2.1.3. Swine
10.1.2.1.4. Equine
10.1.2.2. Companion Animal
10.1.2.2.1. Feline
10.1.2.2.2. Canine
10.1.2.2.3. Avian
10.1.2.2.4. Others
10.1.2.3. Aquaculture
10.1.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.3.1. Oral
10.1.3.2. Parenteral
10.1.3.3. Topical
10.1.3.4. Others
10.1.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.4.1. Veterinary Pharmacies
10.1.4.2. Veterinary Hospitals
10.1.4.3. Veterinary Clinics
10.1.4.4. E-Commerce
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.2. Europe Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.2.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.1.1. Product type
10.2.1.1.1. Drugs
10.2.1.1.1.1. Antibiotics
10.2.1.1.1.2. Antifungal
10.2.1.1.1.3. Ectoparasiticides
10.2.1.1.1.4. Endoparacitides
10.2.1.1.1.5. Endectoparaciticides
10.2.1.1.1.6. Anti-inflammatory Drugs
10.2.1.1.1.7. Drugs for Chronic Diseases
10.2.1.1.1.8. Others
10.2.1.1.2. Vaccines
10.2.1.1.3. Feed Additives
10.2.1.1.3.1. Nutritional Feed Additives
10.2.1.1.3.2. Medicinal Feed Additives
10.2.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.2.1. Farm Animal
10.2.2.1.1. Livestock
10.2.2.1.2. Poultry
10.2.2.1.3. Swine
10.2.2.1.4. Equine
10.2.2.2. Companion Animal
10.2.2.2.1. Feline
10.2.2.2.2. Canine
10.2.2.2.3. Avian
10.2.2.2.4. Others
10.2.2.3. Aquaculture
10.2.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.3.1. Oral
10.2.3.2. Parenteral
10.2.3.3. Topical
10.2.3.4. Others
10.2.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.4.1. Veterinary Pharmacies
10.2.4.2. Veterinary Hospitals
10.2.4.3. Veterinary Clinics
10.2.4.4. E-Commerce
10.2.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.2.5.1. Germany
10.2.5.2. UK
10.2.5.3. France
10.2.5.4. Spain
10.2.5.5. Italy
10.2.5.6. Russia
10.2.5.7. Poland 10.2.5.8. Rest of Europe
10.3. Asia-Pacific Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.3.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.1.1. Product type
10.3.1.1.1. Drugs
10.3.1.1.1.1. Antibiotics
10.3.1.1.1.2. Antifungal
10.3.1.1.1.3. Ectoparasiticides
10.3.1.1.1.4. Endoparacitides
10.3.1.1.1.5. Endectoparaciticides
10.3.1.1.1.6. Anti-inflammatory Drugs
10.3.1.1.1.7. Drugs for Chronic Diseases
10.3.1.1.1.8. Others
10.3.1.1.2. Vaccines
10.3.1.1.3. Feed Additives
10.3.1.1.3.1. Nutritional Feed Additives
10.3.1.1.3.2. Medicinal Feed Additives
10.3.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.2.1. Farm Animal
10.3.2.1.1. Livestock
10.3.2.1.2. Poultry
10.3.2.1.3. Swine
10.3.2.1.4. Equine
10.3.2.2. Companion Animal
10.3.2.2.1. Feline
10.3.2.2.2. Canine
10.3.2.2.3. Avian
10.3.2.2.4. Others
10.3.2.3. Aquaculture
10.3.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.3.1. Oral
10.3.3.2. Parenteral
10.3.3.3. Topical
10.3.3.4. Others
10.3.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.4.1. Veterinary Pharmacies
10.3.4.2. Veterinary Hospitals
10.3.4.3. Veterinary Clinics
10.3.4.4. E-Commerce
10.3.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.3.5.1. Japan
10.3.5.2. China
10.3.5.3. India
10.3.5.4. ASEAN
10.3.5.5. Australia & New Zealand 10.3.5.6. Rest of Asia-Pacific
10.4. Latin America Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.4.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.1.1. Product type
10.4.1.1.1. Drugs
10.4.1.1.1.1. Antibiotics
10.4.1.1.1.2. Antifungal
10.4.1.1.1.3. Ectoparasiticides
10.4.1.1.1.4. Endoparacitides
10.4.1.1.1.5. Endectoparaciticides
10.4.1.1.1.6. Anti-inflammatory Drugs
10.4.1.1.1.7. Drugs for Chronic Diseases
10.4.1.1.1.8. Others
10.4.1.1.2. Vaccines
10.4.1.1.3. Feed Additives
10.4.1.1.3.1. Nutritional Feed Additives
10.4.1.1.3.2. Medicinal Feed Additives
10.4.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.2.1. Farm Animal
10.4.2.1.1. Livestock
10.4.2.1.2. Poultry
10.4.2.1.3. Swine
10.4.2.1.4. Equine
10.4.2.2. Companion Animal
10.4.2.2.1. Feline
n) and Y-o-Y Growth (%)
10.4.3.1. Oral
10.4.3.2. Parenteral
10.4.3.3. Topical
10.4.3.4. Others
10.4.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.4.1. Veterinary Pharmacies
10.4.4.2. Veterinary Hospitals
10.4.4.3. Veterinary Clinics
10.4.4.4. E-Commerce
10.4.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.4.5.1. Brazil
10.4.5.2. Mexico
10.4.5.3. Argentina
10.4.5.4. Venezuela
10.4.5.5. Rest of Latin America
10.5. Middle East & Africa (MEA) Veterinary Healthcare Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.5.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.1.1. Product type
10.5.1.1.1. Drugs
10.5.1.1.1.1. Antibiotics
10.5.1.1.1.2. Antifungal
10.5.1.1.1.3. Ectoparasiticides
10.5.1.1.1.4. Endoparacitides
10.5.1.1.1.5. Endectoparaciticides
10.5.1.1.1.6. Anti-inflammatory Drugs
10.5.1.1.1.7. Drugs for Chronic Diseases
10.5.1.1.1.8. Others
10.5.1.1.2. Vaccines
10.5.1.1.3. Feed Additives
10.5.1.1.3.1. Nutritional Feed Additives
10.5.1.1.3.2. Medicinal Feed Additives
10.5.2. Animal Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.2.1. Farm Animal
10.5.2.1.1. Livestock
10.5.2.1.2. Poultry
10.5.2.1.3. Swine
10.5.2.1.4. Equine
10.5.2.2. Companion Animal
10.5.2.2.1. Feline
10.5.2.2.2. Canine
10.5.2.2.3. Avian
10.5.2.2.4. Others
10.5.2.3. Aquaculture
10.5.3. Route of Administration Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.3.1. Oral
10.5.3.2. Parenteral
10.5.3.3. Topical
10.5.3.4. Others
10.5.4. Distribution Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.4.1. Veterinary Pharmacies
10.5.4.2. Veterinary Hospitals
10.5.4.3. Veterinary Clinics
10.5.4.4. E-Commerce
10.5.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
10.5.5.1. Gulf Cooperation Council (GCC) Countries
10.5.5.2. Israel
10.5.5.3. South Africa
10.5.5.4. Rest of MEA
11. COMPETITION LANDSCAPE
11.1. Strategic Dashboard of Top Market Players
11.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
11.2.1. Bayer AG (Germany)
11.2.2. Boehringer Ingelheim GmbH (Germany)
11.2.3. Cargill, Inc. (U.S)
11.2.4. Ceva Santé Animale (France)
11.2.5. Eli Lilly and Company (U.S)
11.2.6. Koninklijke DSM N.V. (Netherlands)
11.2.7. Merck & Co., Inc. (U.S)
11.2.8. Novartis AG (Switzerland)
11.2.9. Nutreco N.V. (Netherlands)
11.2.10. SeQuent Scientific Ltd. (India)
11.2.11. Vétoquinol S.A. (France)
11.2.12. Virbac S.A. (France)
11.2.13. Zoetis Inc. (
